Weekly Pharma & Life Sciences News Round-Up: 25th – 29th July
A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 25th-29th July.
Scottish health researchers are at the forefront of a new €6m project to make Artificial Intelligence-assisted (AI) capsule endoscopy a part of future bowel cancer diagnostics.
Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has been recognised for its innovative approach to workplace flexibility.
Pleco Therapeutics BV announces its expansion, with the incorporation of Pleco Therapeutics USA, Inc., alongside the appointment of Michael Stalhamer as its President and first employee.
A new General Internal Medicine (GIM) specialty has been launched by Health Education England (HEE) to address the growing need for physicians who can deliver care for a range of complex conditions.
NeoPhore Limited, a small molecule neoantigen immuno-oncology company, announces that it has entered a three-year research collaboration agreement with Memorial Sloan Kettering Cancer Center (MSK) in New York, USA.
Velocity Clinical Research, the leading integrated research site organisation, announces it has acquired its first European site, Clinical Research Hamburg, in Germany for an undisclosed amount.
PCI Pharma Services (PCI), announces a significant expansion of its world-class facility in Tredegar, Wales, UK, designed to help keep pace with the market growth of powerful, targeted oncology therapies.
Labcorp announces that its Board of Directors has authorized the Company to pursue a spin-off of the Company’s wholly owned Clinical Development business to Labcorp shareholders through a tax-free transaction.
Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.
Labcorp announces that it scored 100, the highest score possible, on the 2022 Disability Equality Index (DEI), a comprehensive benchmarking tool for measuring disability inclusion in the workplace.
Dr. Philipp Kolb from the Institute of Virology at the University of Freiburg is the first winner of the Renate & Hans Schleussner Research Award.
Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with many patients dying and others left with long-term kidney damage requiring lifelong dialysis and resulting in early death.
Valo Therapeutics Oy announces the exclusive licensing of intellectual property rights (IPR) from the University of Helsinki, Finland, for the institution’s innovative PeptiCHIP technology.
PreciPoint Group GmbH has successfully closed its Series A financing round of EUR 10 million. Existing investors, including bm-t beteiligungsmanagement thüringen gmbh (bm|t), and a new family office invested in the German MedTech startup.
Regeneron Pharmaceuticals, Inc. today announced the winners of the 10th annual Regeneron Prize for Creative Innovation, a competition designed to recognize excellence and creativity in biomedical research conducted by postdoctoral fellows and graduate students.